Rankings
▼
Calendar
CCCC Q2 2022 Earnings — C4 Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CCCC
C4 Therapeutics, Inc.
$243M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+41.4% YoY
Gross Profit
-$17M
-126.4% margin
Operating Income
-$27M
-197.9% margin
Net Income
-$27M
-198.1% margin
EPS (Diluted)
$-0.56
QoQ Revenue Growth
+80.7%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$23M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$492M
Total Liabilities
$148M
Stockholders' Equity
$345M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$10M
+41.4%
Gross Profit
-$17M
-$14M
-29.5%
Operating Income
-$27M
-$22M
-23.8%
Net Income
-$27M
-$23M
-21.4%
← FY 2022
All Quarters
Q3 2022 →